Results 1 to 10 of about 515,262 (372)

Eliminating Plasmodium falciparum malaria: results from tailoring active case detection approaches to remote populations in forested border areas in north-eastern Cambodia

open access: yesMalaria Journal, 2021
Background Remaining Plasmodium falciparum cases in Cambodia are concentrated in forested border areas and in remote populations who are hard to reach through passive case detection.
Ann-Sophie Stratil   +9 more
doaj   +1 more source

A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

open access: yesMalaria Journal, 2023
Background Until recently, due to widespread prevalence of molecular markers associated with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern Africa, seasonal malaria chemoprevention (SMC) has not been used at scale in ...
Anthony Nuwa   +20 more
doaj   +1 more source

Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022

open access: yesBulletin of the National Research Centre, 2023
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi   +11 more
doaj   +1 more source

Optimizing the role of ‘lead mothers’ in seasonal malaria chemoprevention (SMC) campaigns: formative research in Kano State, northern Nigeria

open access: yesMalaria Journal, 2023
Background Seasonal malaria chemoprevention (SMC) is a safe and effective intervention for preventing malaria in children under 5 years of age. Lead mothers are community health volunteers that help caregivers comply with monthly administration of anti ...
Ekechi Okereke   +15 more
doaj   +1 more source

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo

open access: yesMalaria Journal, 2023
Background Malaria is the leading cause of morbidity and mortality among infants and children under-five in sub-Saharan Africa. In the Sahel, seasonal malaria chemoprevention (SMC) is delivered door-to-door in monthly cycles.
Taiwo Ibinaiye   +6 more
doaj   +1 more source

Artemisinin resistance in Plasmodium falciparum malaria.

open access: yesNew England Journal of Medicine, 2009
BACKGROUND Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease.
A. Dondorp   +22 more
semanticscholar   +1 more source

Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study

open access: yesBMC Health Services Research, 2022
Background Bi-annual high dose vitamin A supplements administered to children aged 6–59 months can significantly reduce child mortality, but vitamin A supplementation (VAS) coverage is low in Nigeria.
Olusola Oresanya   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy